A nationwide Estrogen patch shortage is leaving U.S. women struggling to access hormone therapy, with rising demand after safety warnings were lifted, outpacing supply and disrupting treatment for menopausal patients.
Rising Demand Strains Limited Supply
Women across the United States are facing prolonged shortages of estrogen patches, a key treatment for menopause symptoms and certain medical conditions. The issue has persisted for more than a year, with patients often unable to refill prescriptions on time as the Estrogen patch shortage continues to affect availability.
The shortage intensified after federal regulators removed long-standing safety warnings on hormone therapy in 2025. The change reassured doctors and patients, leading to a surge in prescriptions.
Health data firm Truveta reports a 26% increase in estrogen patch use since the warnings were lifted. However, manufacturing and supply chains have not kept pace with demand.
“I probably get a couple messages per day from patients who haven’t been able to locate their patches,” said nurse practitioner Terese Quale of Rockwood Clinic. She warned shortages could last “a few years.”
Patients Face Health Risks and Disruptions
For many women, inconsistent access to hormone therapy is more than an inconvenience. Symptoms of menopause, including hot flashes, mood swings and sleep disruption, can return quickly when treatment lapses due to the ongoing Estrogen patch shortage.
Some patients face more serious risks. Birgitta Hendron, who has premature ovarian insufficiency, depends on hormone therapy to reduce her risk of osteoporosis.
“I have had lapses in the treatment because of the shortage,” Hendron said. “I will literally die young if I don’t have HRT.”
Others describe the physical toll of inconsistent treatment. Spokane wellness coach Stephanie Shimkus said gaps in medication leave her feeling “just sick.” The ongoing Estrogen patch shortage has made it increasingly difficult for patients to maintain consistent therapy.
“With hormones, you want continuity,” Shimkus said. “Having this game of having estrogen and then not having estrogen can be much more disruptive.”
Patients report waiting two to four weeks for refills and often traveling across cities to find available supplies.
Limited Alternatives Add to Challenges
Doctors recommend alternative forms of estrogen, including pills, gels, sprays and vaginal rings. While more available, these options can be harder to access due to higher costs or insurance barriers.
Oral medications also carry a small increased risk of blood clots, making them less suitable for some patients.
“Once you find something that works really well for you, it can be really alarming to not have that as an option,” Quale said, adding that alternatives remain important stopgaps amid the ongoing Estrogen patch shortage.
Hendron said she has been unable to obtain more than a one-month supply at a time despite being prescribed three months. She is also limited by allergic reactions to certain patch adhesives.
Shimkus criticized pharmaceutical companies and regulators for failing to anticipate demand following the policy change.
“This doesn’t need to happen,” she said. “It’s a lack of planning.”
Patients and providers say the shortages highlight broader gaps in women’s health care, particularly for older women who may struggle to advocate for consistent treatment.
As supply issues continue, the Estrogen patch shortage remains a major concern, leaving many uncertain about when reliable access to treatment will return.
